Improving women’s healthcare providers’ knowledge about fragile X-associated primary ovarian insufficiency through a novel educational tool

Le résumé fourni par la source

PURPOSE: Gaps in knowledge among women's healthcare providers have contributed to diagnostic delays and delayed care for women with fragile X-associated primary ovarian insufficiency (FXPOI). The objective of this study was to assess if an educational tool could improve women's healthcare providers' knowledge of FXPOI. METHODS: A one-page educational tool about the premutation and FXPOI was developed. To assess the impact, a pre- and post-intervention survey was given to 95 providers. The post-intervention survey was emailed approximately 1 month after the pre-intervention survey. Surveys consisted of 12 knowledge-based questions (12 points total). Additional information collected included demographics, routine POI workup, comfort level explaining carrier screening results, and feedback on the tool. RESULTS: Provider knowledge significantly improved from 7.34/12 (± 1.75) to 8.66/12 (± 2.30) (p < 0.0001). Significant predictors of pre-intervention knowledge included provider type, specialty, presence of a genetic counselor (GC) in clinic, and graduation year. Physicians outperformed nurse practitioners and nurse midwives (p < 0.0128). Reproductive endocrinologists and maternal-fetal medicine providers outperformed other specialties (p < 0.0001). Providers with a GC in the clinic performed better than those without (p = 0.0128). Providers who graduated between 2010 and 2019 outperformed more recent graduates (p = 0.0348). No significant predictors were identified for post-intervention scores. CONCLUSIONS: The implementation of our novel educational tool led to measurable improvement in provider knowledge regarding FXPOI and the fragile X premutation. The absence of significant demographic predictor variables on the post-intervention survey suggests that the educational tool may help reduce provider gaps in knowledge and ultimately reduce time to diagnosis and improve reproductive care for women with FXPOI.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.